T2007-002 A Phase II Study of Clofarabine With Etoposide and Cyclophosphamide in Relapsed/Refractory AML (IND 104,650)
Phase of Trial: Phase II
Latest Information Update: 01 May 2017
At a glance
- Drugs Clofarabine; Cyclophosphamide; Cytarabine; Etoposide; Filgrastim; Filgrastim
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 07 Mar 2012 Actual patient number (7) added as reported by ClinicalTrials.gov.
- 07 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Jul 2009 New trial record.